Hyperaldosteronism
Appearance
The unregulated release of excess aldosterone from one or both adrenal glands
Epidemiology
[edit | edit source]- Believed to affect about 1-7% of patients with HTN
- Mean age at diagnosis 50yo
- Slight male predilection
Aetiology
[edit | edit source]- Primary hyperaldosteronism:
- Autonomous overproduction of aldosterone by the adrenal glands, and not suppressed by sodium loading.
- Unilateral aldosterone-producing adenomas (most common)
- Bilateral adrenal hyperplasia (aka 'idiopathic hyperaldosteronism')
- Familial hyperaldosteronism
- Autonomous overproduction of aldosterone by the adrenal glands, and not suppressed by sodium loading.
Presentation
[edit | edit source]- HTN - often moderate-to-severe that is refractory to medical therapy
- Responsiveness to spironolactone is a good prognostic factor for surgery
- Most patients are otherwise asymptomatic
- Hypokalaemia (found in less than 40% of patients with primary aldosteronism - likely severe or late-stage disease)
- Can be a/w cardiovascular disease, including LVH, AF, MI, CVA
- These may regress with cure
- Classically, Conn's syndrome - HTN, polyuria-polydipsia, and hypokalaemia
Workup indications:
[edit | edit source]- HTN and spontaneous, or low-dose diuretic-induced, hypokalaemia
- Severe HTN or drug-resistant HTN (on three-drug program including adrenergic inhibitor, vasodilator and diuretic)
- HTN with adrenal incidentaloma
- HTN with OSA
- HTN and family history of early-onset HTN or CVA<40yo
- HTN and first-degree relative of patient with primary hyperaldosteronism
- HTN and AF
Workup:
[edit | edit source]- Initial testing:
- Establish ratio of plasma aldosterone to renin
- Discontinue spironolactone, ACE inhibitors, diuretics and beta-blockers beforehand
- Common normal range cut-off of >30:1 gives a sensitivity of 90%. Using a cut-off of >20:1 instead increases sensitivity at cost of specificity; this reflects appreciation of the clinical gravity of missing surgically correctable hyperaldosteronism.
- Also good to require absolute aldosterone concentration >15mg/dL, since otherwise some patients with fairly normal aldosterone but low renin would meet criteria
- Plasma renin activity or plasma renin concentration reduced (typically undetectable)
- Plasma aldosterone concentration is inappropriately high for renin
- Establish ratio of plasma aldosterone to renin
- Confirmatory testing:
- Confirm that high aldosterone levels are non-suppressible with either IV sodium loading (2-3L of isotonic saline over 4-6 hours, followed by measurement of plasma aldosterone) or oral salt loading (5g sodium daily for three days, followed by measurement of 24-hour aldosterone excretion)
- Localisation
- CT - differentiate between adrenal hyperplasia and adenoma
- Adenomas are typically <2cm, aldosterone-producing carcinomas are almost always >4cm
- Thin-cut (3mm) adrenal CT
- Adrenal vein sampling
- Indications
- Strong indication: Normal CT or bilateral abnormalities
- Weak indication: When there is a higher chance that the identified lesion is a unilateral non-functioning cortical adenoma, and you may be missing a contralateral micro-aldosteronoma or bilateral adrenal hyperplasia
- Some say patients >40yo with primary hyperaldosteronism
- Some say all patients with primary hyperaldosteronism
- Simultaneous measurement of cortisol and aldosterone levels in the peripheral circulation and left and right adrenal veins
- Lateralisation is indicated by a four-fold ratio between sides
- Indications
- CT - differentiate between adrenal hyperplasia and adenoma
- Genetic screening for patients that test positive at <30yo for familial hyperaldosteronism type I, especially if they have a family history of early-onset HTN
Surgery
[edit | edit source]- Indications
- Unilateral disease, either adenoma or hyperplasia, which is causing primary aldosteronism
- Approach
- See separate topic under 'operations'
- Cure metrics
- Complete - normal BP (less likely in patients that have underlying essential HTN)
- Partial - decrease in antihypertensive medication
- Absent
- Post-op
- Stop all antihypertensive medications immediately post-op, with the exception of beta-blockers and clonidine to avoid rebound. Add back in as needed.
- Hyperaldosteronism can mask the true degree of CKD due to glomerular hyperfiltration
- Hyperkalaemia, related to renal function, occurs 1-3 weeks post-op - monitor with weekly UEC. Persistent hyperkalaemia can be treated with mineralocorticoid replacement (fludrocortisone).
Medical treatment
[edit | edit source]- Those unfit for surgery can be treated with mineralocorticoid receptor antagonists (spironolactone or eplerenone)